OpenAlex
PricingAboutJobs
Log inGet started
Work

Semaglutide Effect on Kidney, Cardiovascular, and Mortality Outcomes in Racial and Ethnic Groups: FLOW Trial Post Hoc Analyses

HTML

Year: 2026
Type: article
Source: Clinical Journal of the American Society of Nephrology
DOI: 10.2215/cjn.0000001242
Authors: Carlos Campos, Richard Pratley, Sherif Mehanna, Caroline Swift, Søren Rasmussen, Peter Rossing, Katherine Tuttle, Kenneth W. Mahaffey, Robert Busch, David M. Charytan, Christian Mende
Institutions: AdventHealth Orlando, AdventHealth, Novo Nordisk (Denmark), Steno Diabetes Center Copenhagen, University of Washington, Inland Northwest Health Services, Stanford Medicine, Stanford University, Albany Med Health System, New York University, University of California San Diego
Language: English

Topic: Diabetes Treatment and Management
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: semaglutide, chronic kidney disease, type 2 diabetes, racial and ethnic disparities, Black patients, Hispanic patients, renal failure, estimated glomerular filtration rate decline, major adverse cardiovascular events, all-cause mortality, GLP-1 receptor agonists, FLOW trial
SDGs: Good health and well-being, Reduced inequalities

Open Access status: closed
OpenAlex ID: W7236314031
FWCI:
Cites:
Cited by:
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security